X
XLinkedinWhatsAppTelegramTelegram
1
5

MSD launches IDAL® 3G Needle-free, intradermal swine vaccination device

1 comments

“The IDAL® Way” features newest device with broadest vaccine portfolio for control of major diseases affecting swine.

12 April 2018
X
XLinkedinWhatsAppTelegramTelegram
1
5

MSD Animal HealthMSD Animal Health today announced the launch of IDAL® 3G, the newest needle-free, intradermal delivery device in the IDAL® family of products for swine vaccination, and “The IDAL® Way,” an extended vaccine portfolio designed for intradermal use.

“The IDAL® Way” offers five intradermal swine vaccines for administration with the IDAL® 2G and the new IDAL® 3G, including PORCILIS® PCV ID, PORCILIS® M Hyo ID ONCE, PORCILIS® PRRS, PORCILIS® AD Begonia and PRIME PAC™ PRRS, an important step forward in controlling the major diseases affecting swine operations worldwide.

“Needle-free, intradermal application of vaccines is the most advanced method for vaccinating swine today, and The IDAL® Way is key for the future of swine production,” said Olivia Azlor, MBA, Director, Global Swine Marketing, MSD Animal Health. “We are proud to introduce the IDAL® 3G, which is designed to improve convenience and ease-of-use for producers, making vaccination safe and less stressful for pigs and people, while ensuring disease prevention with the broadest range of vaccines designed for intradermal administration.”

The third generation of the company’s needle-free IDAL® vaccine delivery system, IDAL®

3G has additional features that make the system easier to use. With a long-lasting Li-Ion battery and nearly twice the service interval of the IDAL® 2G, the IDAL® 3G also has a new balanced design, ergonomically shaped two-component surface for maximum grip, and intuitive handling with two-button control and graphical display.

The five intradermal swine vaccines for administration with IDAL® 2G and IDAL® 3G can protect swine from porcine reproductive and respiratory syndrome virus (PRRSv) and PRRSv-2, porcine circovirus type 2 (PCV2), Mycoplasma hyopneumoniae (M Hyo) and Aujeszky’s disease virus infections (pseudorabies):

  • PORCILIS® PRRS: Modified live vaccine for immunization against PRRSv throughout the production system from as early as two week of age
  • PRIME PAC PRRS: Modified live vaccine for immunization of pigs as early as 2 weeks of age against PRRSv-2
  • PORCILIS® PCV ID: The first intradermal PCV vaccine for active immunization of pigs as early as 3 weeks of age to reduce PCV2 viremia, viral load in lung and lymphoid tissue and virus shedding in addition to loss of daily weight gain and mortality associated with a PCV2 infection
  • PORCILIS® M HYO ID ONCE: One-dose vaccine for immunization of piglets as early as 3 weeks of age to reduce lung lesions and decrease in daily weight gain during the finishing period following a Mycoplasma hyopneumoniae infection
  • PORCILIS® AD BEGONIA: Live, attenuated vaccine for the immunization of pigs against Aujeszky’s disease virus (Pseudorabies) infections

Producers and veterinarians can contact their MSD Animal Health representative for more information.

April 11, 2018 – MSD Animal Health

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
17-Sep-2023 min-soelet me know IDAL price and CNF Yangon
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list Swine News

Swine industry news in your email

Log in and sign up on the list

MSD Animal Health